Determining the effect of selenium supplement on inflammatory, oxidative and nutritional markers in hemodialysis patients in shiraz medical university hemodialysis centers
Phase 2
- Conditions
- End stage renal disease.End-stage renal disease
- Registration Number
- IRCT138812083446N1
- Lead Sponsor
- Shiraz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
being on dialysis at least 2-3 sessions per week for 3 months, age range of 17-85 years. Exclusion criteria: being admitted in hospital during last month, having active infection, using multivitamins or immunosupressive drugs, being pregnant.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method